PROPENOATDERIVATE AUS BETULIN

European patent · EP2791102 · Deleted

Register entry

Publication number
EP2791102
Application number
EP12856832
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 14, 2012
Published
Oct 22, 2014
Granted
May 18, 2016
Deleted
Dec 31, 2016
Reason
Annual fee unpaid
IPC classes
C07C 69/753 (2006.01)
C07J 63/00 (2006.01)
A61K 31/56 (2006.01)
A61P 31/18 (2006.01)
Priority
WO PCT/CN2011/002105 14.12.2011
WO PCT/CN2011/002159 21.12.2011
PCT application
PCT/US2012/069688 14.12.2012
PCT publication
WO2013/090683 20.06.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 19, 2017

    Deleted, fee unpaid

    Published in Swissreg on 19.07.2017

  2. May 18, 2016

    Granted

    Published in Swissreg on 18.05.2016

Parties

Holder

GlaxoSmithKline LLC

Corporation Service Company 2711 Centerville Road Suite 400, Wilmington DE 19808, US

Inventor

HAN, Nianhe

Shanghai 201203, CN

JOHNS, Brian Alvin

Research Triangle Park North Carolina 27709, US

TANG, Jun

Research Triangle Park North Carolina 27709, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.